Price Targets For Hansa Biopharma

Stockholm Stock Exchange

Hansa Biopharma

+19.22% (5.32)

DNB CarnegieCarnegieSEBSEB EquitiesRBC

Latest Target

+19.22%

33.00 SEK

DNB Carnegie

Nov -25

33.00 SEK

All Price Targets For Hansa Biopharma

DNB Carnegie

Nov -25

Target: 33.00 SEKPrice: 27.68 SEK

+19.22%

Carnegie

Feb -25

Target: 32.00 SEKPrice: 27.68 SEK

+15.61%

SEB

Jul -24

Target: 130.00 SEKPrice: 27.68 SEK

+369.65%

SEB Equities

Jul -24

Target: 50.00 SEKPrice: 27.68 SEK

+80.64%

RBC

Jun -22

Target: 172.00 SEKPrice: 27.68 SEK

+521.39%

About The Company

Hansa Biopharma AB is a Swedish biopharmaceutical company developing immunomodulatory enzyme treatments for rare immunological conditions. The company focuses on developing treatments for organ transplantation and autoimmune diseases.
Wikipedia